Skip to main content

Table 3 Chemotherapy-induced toxicity (NCI-CTC version 2.0)

From: Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study

  Grade 1, n Grade 2, n Grade 3, n Grade 4, n
Neutropenia 0 3 1 0
Thrombocytopenia 2 1 0 0
Anemia 0 2 1 0
Diarrhea 10 4 1 0
Nausea-vomiting 10 9 2 0
Alopecia 3 0 0 0
Hand-foot syndrome 0 1 0 0
mucositis 6 0 2 0
Neurotoxicity 3 3 4 0
Asthenia 9 7 3 0
Allergic reaction 0 1 0 0
Maximum/patient (%) 4 (12,9) 15 (48,4) 6 (19,3) 0 (0)
  1. NCI-CTC: National Cancer Institute Common Toxicity Criteria.